drugset / Trial / NCT03371329
Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage
Non-randomizedSequentialOpen-labelTreatment
Summary
The overall goal of this study is to develop mesenchymal stem cell therapy for treatment of acute spontaneous hemorrhagic stroke.
Timeline
- Start
- 2017-12-12
- Primary completion
- 2020-10-09
- Completion
- 2020-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | 0.5 cells/kg | Intravenous |
| Subject | Mesenchymal stem cell | Cell therapy | 1 cells/kg | Intravenous |
| Subject | Mesenchymal stem cell | Cell therapy | 2 cells/kg | Intravenous |